StockData
Cryo-Cell International Inc logo

Cryo-Cell International Inc (CCEL) stock

CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026Score 2/30
$4.85−0.55 (-10.19%)

Close on Nov 13, 2026Market cap $39.10MP/E –Yield –

Cryo-Cell International operating margin

Operating margin is operating income as a percentage of revenue.

Cryo-Cell International's operating margin for the twelve months ending Aug 31, 2026 was 0.6%. For fiscal 2025 it was 1.5%, against 10.9% the year before. The highest annual figure on record is 24.6% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Nov 30, 20251.5%−9.4
FY2024Nov 30, 202410.9%+50.1
FY2023Nov 30, 2023-39.3%−52.5
FY2022Nov 30, 202213.3%−0.6
FY2021Nov 30, 202113.9%−10.7
FY2020Nov 30, 202024.6%+8.7
FY2019Nov 30, 201915.9%−1.8
FY2018Nov 30, 201817.8%−2.0
FY2017Nov 30, 201719.7%+17.8
FY2016Nov 30, 20161.9%−12.0
FY2015Nov 30, 201513.9%+4.1
FY2014Nov 30, 20149.8%+0.9
FY2013Nov 30, 20139.0%+18.5
FY2012Nov 30, 2012-9.5%−8.0
FY2011Nov 30, 2011-1.5%−20.4
FY2010Nov 30, 201018.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ3 2026Aug 31, 202628.0%+3.8
Q2 FY2026CQ2 2026May 31, 202615.4%−3.4
Q1 FY2026CQ1 2026Feb 28, 202610.0%−3.3
Q4 FY2025CQ4 2025Nov 30, 2025-50.6%−49.1
Q3 FY2025CQ3 2025Aug 31, 202524.3%+7.1
Q2 FY2025CQ2 2025May 31, 202518.8%+1.5
Q1 FY2025CQ1 2025Feb 28, 202513.3%+2.8
Q4 FY2024CQ4 2024Nov 30, 2024-1.5%+203.8
Q3 FY2024CQ3 2024Aug 31, 202417.2%+2.5
Q2 FY2024CQ2 2024May 31, 202417.3%+4.1
Q1 FY2024CQ1 2024Feb 29, 202410.5%−11.1
Q4 FY2023CQ4 2023Nov 30, 2023-205.4%−210.6
Q3 FY2023CQ3 2023Aug 31, 202314.8%+2.3
Q2 FY2023CQ2 2023May 31, 202313.2%−2.4
Q1 FY2023CQ1 2023Feb 28, 202321.5%+1.3
Q4 FY2022CQ4 2022Nov 30, 20225.2%+16.3
Q3 FY2022CQ3 2022Aug 31, 202212.4%−8.8
Q2 FY2022CQ2 2022May 31, 202215.6%−12.0
Q1 FY2022CQ1 2022Feb 28, 202220.3%+2.3
Q4 FY2021CQ4 2021Nov 30, 2021-11.1%−40.0
Q3 FY2021CQ3 2021Aug 31, 202121.3%−9.3
Q2 FY2021CQ2 2021May 31, 202127.7%+5.4
Q1 FY2021CQ1 2021Feb 28, 202118.0%+1.6
Q4 FY2020CQ4 2020Nov 30, 202028.9%+7.3
Q3 FY2020CQ3 2020Aug 31, 202030.6%+6.3
Q2 FY2020CQ2 2020May 31, 202022.3%+16.1
Q1 FY2020CQ1 2020Feb 29, 202016.4%+5.0
Q4 FY2019CQ4 2019Nov 30, 201921.6%−3.2
Q3 FY2019CQ3 2019Aug 31, 201924.2%+12.5
Q2 FY2019CQ2 2019May 31, 20196.1%−11.5
Q1 FY2019CQ1 2019Feb 28, 201911.4%−4.5
Q4 FY2018CQ4 2018Nov 30, 201824.8%+5.6
Q3 FY2018CQ3 2018Aug 31, 201811.7%−9.4
Q2 FY2018CQ2 2018May 31, 201817.6%−1.5
Q1 FY2018CQ1 2018Feb 28, 201815.8%−3.5
Q4 FY2017CQ4 2017Nov 30, 201719.2%+11.5
Q3 FY2017CQ3 2017Aug 31, 201721.1%–
Q2 FY2017CQ2 2017May 31, 201719.1%–
Q1 FY2017CQ1 2017Feb 28, 201719.3%–
Q4 FY2016CQ4 2016Nov 30, 20167.8%–

More Cryo-Cell International figures

See a number that looks wrong?